{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:53:12Z","timestamp":1782978792891,"version":"3.54.5"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.yebeh.2014.07.003","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T14:30:56Z","timestamp":1408545056000},"page":"290-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Atherosclerosis in epilepsy: Its causes and implications"],"prefix":"10.1016","volume":"41","author":[{"given":"Sherifa A.","family":"Hamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2014.07.003_bb0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1006\/ebeh.2000.0104","article-title":"The ILAE\/IBE\/WHO Global Campaign against Epilepsy: bringing epilepsy \u201cout of the shadows\u201d","volume":"1","author":"Reynolds","year":"2000","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0730","series-title":"The eighth international symposium","first-page":"365","article-title":"Epilepsy in the African continent","author":"Osuntoku","year":"1977"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0010","series-title":"Epilepsy: a comprehensive textbook","first-page":"47","article-title":"Incidence and prevalence","author":"Hauser","year":"1997"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0015","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1111\/j.1600-0404.2005.00523.x","article-title":"Behaviour, cognition and epilepsy","volume":"112","author":"Aldenkamp","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1528-1167.2006.00884.x","article-title":"Elderly people and epilepsy: cognitive function","volume":"47","author":"Piazzini","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1474-4422(08)70018-8","article-title":"The neurobehavioural comorbidities of epilepsy: can a natural history be developed?","volume":"7","author":"Hermann","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1755-5949.2008.00062.x","article-title":"The aspects and mechanisms of cognitive alterations in epilepsy: the role of antiepileptic medications","volume":"15","author":"Hamed","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0035","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.yebeh.2003.08.019","article-title":"Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy","volume":"4","author":"Jones","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2008.08.013","article-title":"Factors associated with health-related quality of life, anxiety and depression among young adults with epilepsy and mild cognitive impairments in short-term residential care","volume":"18","author":"Endermann","year":"2009","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.yebeh.2014.07.003_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5316\/wjn.v2.i1.1","article-title":"Depression in adults with epilepsy: relationship to psychobiological variables","volume":"2","author":"Hamed","year":"2012","journal-title":"World J Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5498\/wjp.v2.i2.33","article-title":"The risks of suicidality in adult patients with epilepsy","volume":"2","author":"Hamed","year":"2012","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.yebeh.2013.01.022","article-title":"Psychopathological and peripheral level of neurobiological correlates of obsessive compulsive symptoms with epilepsy: a hospital-based study","volume":"27","author":"Hamed","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0060","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1528-1167.2012.03528.x","article-title":"The somatic comorbidity of epilepsy: a weighty but often unrecognized burden","volume":"53","author":"Gaitatzis","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-1211(01)00288-1","article-title":"Antiepileptic drugs as independent predictors of plasma total homocysteine levels","volume":"47","author":"Apeland","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.seizure.2005.11.002","article-title":"Effect of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6","volume":"15","author":"Sener","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1254\/jphs.CRJ05003X","article-title":"The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins","volume":"98","author":"Hamed","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2007.03.010","article-title":"Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy","volume":"74","author":"Hamed","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0404.1991.tb04691.x","article-title":"Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital","volume":"83","author":"Calandre","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(00)00119-4","article-title":"The effects on lipid and apolipoprotein on serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy","volume":"41","author":"Eris","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s004150070111","article-title":"Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patients","volume":"247","author":"Schwaninger","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.eplepsyres.2006.05.002","article-title":"Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy","volume":"70","author":"Voudris","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0105","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/epi.12338","article-title":"Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy","volume":"54","author":"Kim","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"39","author":"Isojarvi","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0115","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1528-1167.2006.00546.x","article-title":"Characterization of insulin secretion in valproate-treated patients with epilepsy","volume":"47","author":"Pylvanen","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2007.04.001","article-title":"Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions","volume":"75","author":"Hamed","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpn.2008.05.005","article-title":"States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain","volume":"13","author":"Hamed","year":"2009","journal-title":"Eur J Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0130","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1046\/j.1528-1157.2001.042007930.x","article-title":"Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy","volume":"42","author":"Isoj\u00e4rvi","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0887-8994(01)00279-X","article-title":"Thyroid hormones in epileptic children receiving carbamazepine and valproic acid","volume":"25","author":"Verrotti","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eplepsyres.2005.08.004","article-title":"Serum thyroid hormone balance and lipid profile in patients with epilepsy","volume":"66","author":"Hamed","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0145","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1254\/jphs.FPJ04032X","article-title":"Blood levels of trace elements, electrolytes and oxidative stress\/antioxidant systems in epileptic patients","volume":"96","author":"Hamed","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0150","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","article-title":"Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eplepsyres.2007.11.005","article-title":"Increased oxidative stress in epileptic children treated with valproic acid","volume":"78","author":"Verrotti","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/08830738030180021301","article-title":"Epilepsy, atherosclerosis, myocardial infarction, and carbamazepine","volume":"18","author":"de Chadarevian","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0170","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.braindev.2008.11.001","article-title":"Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid","volume":"31","author":"Erdemir","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0175","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1528-1167.2009.02024.x","article-title":"Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis","volume":"50","author":"Tan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0180","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1017\/S1047951110000697","article-title":"Assessment of low-density lipoprotein oxidation, paraoxonase activity, and arterial distensibility in epileptic children who were treated with anti-epileptic drugs","volume":"20","author":"Yildiz","year":"2010","journal-title":"Cardiol Young"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0185","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00381-012-1788-7","article-title":"Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate","volume":"28","author":"Tokgoz","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0190","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.eplepsyres.2013.08.011","article-title":"Noninvasive screening for preclinical atherosclerosis in children on phenytoin or carbamazepine monotherapy: a cross sectional study","volume":"107","author":"Sankhyan","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0195","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1528-1157.1984.tb03480.x","article-title":"Heart disease mortality and morbidity in patients with epilepsy","volume":"25","author":"Annegers","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0200","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/bmj.291.6507.1481","article-title":"Mortality from ischemic heart disease among the patients using anticonvulsive drugs: a case\u2013control study","volume":"291","author":"Muuronen","year":"1985","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0205","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ana.70","article-title":"Mortality in epilepsy in the first 11 to 14years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort","volume":"49","author":"Lhatoo","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1528-1167.2012.03693.x","article-title":"Comparative stroke risk of antiepileptic drugs in patients with epilepsy","volume":"54","author":"Hsieh","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0215","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(04)15946-1","article-title":"Late-onset seizures as a predictor of subsequent stroke","volume":"363","author":"Cleary","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.seizure.2014.02.007","article-title":"Patients with epilepsy are at an increased risk of subsequent stroke: a population-based cohort study","author":"Chang","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0225","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0140-6736(12)61455-X","article-title":"Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan","volume":"380","author":"Lin","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0230","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yebeh.2005.05.003","article-title":"What are the concerns of older adults living with epilepsy?","volume":"7","author":"Martin","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/WNL.56.1.42","article-title":"Atherosclerosis Risk in Communities (ARIC) Study Investigators. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0240","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1161\/STROKEAHA.109.557280","article-title":"Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease","volume":"40","author":"Wendell","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0245","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2010.05.006","article-title":"Subclinical atherosclerosis is related to lower neuronal viability in middle-aged adults: a 1H MRS study","volume":"1344","author":"Haley","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0250","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1161\/STROKEAHA.108.535245","article-title":"Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study","volume":"40","author":"Romero","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/gps.2351","article-title":"Carotid- intima media thickness is independently associated with cognitive decline. The INVADE study","volume":"25","author":"Sander","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0260","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/01.WNL.0000113759.80877.1F","article-title":"Reduced neuropsychological test performance in asymptomatic carotid stenosis: the Tromso study","volume":"62","author":"Mathiesen","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0265","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/PSY.0b013e31812f7b8e","article-title":"Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression","volume":"69","author":"Smith","year":"2007","journal-title":"Psychosom Med"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0270","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21073","article-title":"Atherosclerosis and risk for dementia","volume":"61","author":"van Oijen","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0275","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.ATV.19.2.356","article-title":"Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the cardiovascular health study. CHS collaborative research group","volume":"19","author":"Manolio","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000054785","article-title":"The incidence of vascular dementia in Canada: a comparison with Europe and East Asia","volume":"20","author":"Dubois","year":"2001","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0285","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ana.10440","article-title":"Homocysteine, white matter hyperintensities, and cognition in healthy elderly people","volume":"53","author":"Dufouil","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0290","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer's disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0295","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresrev.2005.11.007","article-title":"Lipid metabolism in cognitive decline and dementia","volume":"51","author":"Panza","year":"2006","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0300","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2005.08.017","article-title":"High-fat diets, insulin resistance and declining cognitive function","volume":"26","author":"Greenwood","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0305","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.2337\/dc06-0915","article-title":"Hyperinsulinemia and cognitive decline in a middle-aged cohort","volume":"29","author":"Young","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0310","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/brain\/awl215","article-title":"fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism","volume":"129","author":"Zhu","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0315","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/187153012802002875","article-title":"Subclinical hypothyroidism and cognitive dysfunction in the elderly","volume":"12","author":"Resta","year":"2012","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0320","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.5114\/aoms.2012.32423","article-title":"Changes of subtests of Wechsler Memory Scale and cognitive function in subjects with subclinical hypothyroidism following treatment with levothyroxine","volume":"8","author":"Aghili","year":"2012","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0325","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2006.06.028","article-title":"The relationship between homocysteine, cognition and stroke subtypes in acute stroke","volume":"250","author":"Tay","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0330","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12603-012-0051-y","article-title":"Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the VITA cohort","volume":"16","author":"Blasko","year":"2012","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0335","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/ijo.2009.104","article-title":"Overweight in midlife and risk of dementia: a 40-year follow up study","volume":"33","author":"Hassing","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0340","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/tp.2012.121","article-title":"Overweight and obesity are associated with neuronal injury in the human cerebellum and hippocampus in young adults: a combined MRI, serum marker and gene expression study","volume":"2","author":"Mueller","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0345","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pscychresns.2013.06.004","article-title":"Frontal cortical thinning and subcortical volume reductions in early adulthood obesity","volume":"214","author":"Marqu\u00e9s-Iturria","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(87)90701-X","article-title":"The frequency of epilepsy preceding stroke. Case\u2013control study in 230 patients","volume":"1","author":"Shinton","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0355","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/clinchem\/41.7.1033","article-title":"Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine","volume":"41","author":"Ubbink","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0360","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-510X(96)00256-0","article-title":"Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy","volume":"145","author":"Kishi","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0365","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/ejpn.2000.0379","article-title":"Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C\u2013>T mutation of the methylenetetrahydrofolate reductase gene","volume":"4","author":"Vilaseca","year":"2000","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0370","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0920-1211(00)00150-9","article-title":"Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine","volume":"41","author":"Verrotti","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0375","first-page":"17","article-title":"Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis","volume":"42","author":"Wegner","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0380","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archneur.59.5.787","article-title":"Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease","volume":"59","author":"Hogervorst","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0385","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/01.STR.0000060203.58958.35","article-title":"Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease","volume":"34","author":"Tanne","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0390","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2011.02.027","article-title":"Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study","volume":"216","author":"Kloppenborg","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0395","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.158.12.1301","article-title":"Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening and treatment","volume":"158","author":"Stein","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0400","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/euhj.1999.1914","article-title":"Homocysteine and atherothrombosis \u2014 mechanisms for injury","volume":"21","author":"Thambyrajah","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0405","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/1389201043489657","article-title":"Moderate hyperhomocysteinemia and immune activation","volume":"5","author":"Schroecksnadel","year":"2004","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0410","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(00)02260-2","article-title":"Effects of homocysteine on the binding of extracellular\u2013superoxide dismutase to the endothelial cell surface","volume":"486","author":"Yamamoto","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0415","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2004.02.008","article-title":"Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels","volume":"175","author":"Riba","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0420","doi-asserted-by":"crossref","first-page":"10193","DOI":"10.1073\/pnas.89.21.10193","article-title":"Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential link between thrombosis, atherogenesis, and sulfhydryl compound metabolism","volume":"89","author":"Harpel","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0425","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1538-7836.2003.00053.x","article-title":"Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia","volume":"1","author":"Sauls","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0430","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pediatrneurol.2008.10.003","article-title":"Effect of carbamazepine therapy on serum lipids in children with partial epilepsy","volume":"40","author":"Aggarwal","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0435","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1528-1157.1994.tb01792.x","article-title":"Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxacarbazepine","volume":"35","author":"Isoj\u00e4rvi","year":"1994","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2014.07.003_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(00)00119-4","article-title":"The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy","volume":"41","author":"Eir\u00eds","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0445","first-page":"50","article-title":"The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy","volume":"10","author":"Nikolaos","year":"2004","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0450","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","article-title":"Clinical importance of the cytochromes P450","volume":"360","author":"Nebert","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0455","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000115130","article-title":"Plasma high-density lipoprotein cholesterol in epileptics treated with various anticonvulsants","volume":"19","author":"Luoma","year":"1980","journal-title":"Eur Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0460","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.metabol.2005.03.013","article-title":"The endothelial cholesterol efflux is promoted by the high density lipoprotein anionic peptide factor","volume":"58","author":"Domingo","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0465","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1172\/JCI110789","article-title":"Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma","volume":"71","author":"Fielding","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0470","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5551\/jat.10.72","article-title":"Relationship between high-density lipoprotein\u2013cholesterol and malondialdehyde modified low-density lipoprotein concentrations","volume":"10","author":"Kondo","year":"2003","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0475","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1059-1311(97)80065-9","article-title":"Weight gain with valproate or carbamazepine \u2014 a reappraisal","volume":"6","author":"Easter","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0480","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10194-005-0221-y","article-title":"Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up","volume":"6","author":"Maggioni","year":"2005","journal-title":"J Headache Pain"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0485","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2005-919109","article-title":"Psychotropic drug-induced changes of weight: a review","volume":"75","author":"Drieling","year":"2007","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0490","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","article-title":"Pregabalin 1008-011 International Study Group. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose response study in adults with partial seizures","volume":"45","author":"Arroy","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0495","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/088307389901400802","article-title":"Risk of excessive weight gain in epileptic children treated with valproate","volume":"14","author":"Novak","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0500","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylvanen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0505","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/jnnp.57.6.682","article-title":"A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG collaborative group","volume":"57","author":"Richens","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0510","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.yebeh.2013.05.012","article-title":"Obesity in adults with epilepsy","volume":"28","author":"Janousek","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0515","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MCA.0b013e3283219e76","article-title":"Body mass index, metabolic syndrome and carotid atherosclerosis","volume":"20","author":"Irace","year":"2009","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0520","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1089\/thy.2007.0116","article-title":"Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?","volume":"17","author":"Duntas","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0525","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/meta.2002.31323","article-title":"Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A\u2013I in the rat","volume":"51","author":"Huesca-G\u00f3mez","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0530","first-page":"643","article-title":"Subclinical hypothyroidism with emphasis on the cardiovascular system","volume":"142","author":"Spacilova","year":"2003","journal-title":"Cas Lek Cesk"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0535","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0272-6386(98)70067-8","article-title":"Regulation of renal urate excretion: a critical review","volume":"32","author":"Maesaka","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0540","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semnephrol.2004.09.007","article-title":"Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease","volume":"25","author":"Kanellis","year":"2005","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0545","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1194\/jlr.M200407-JLR200","article-title":"Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid","volume":"44","author":"Patterson","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0550","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0570","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1749-6632.2000.tb06394.x","article-title":"Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease?","volume":"903","author":"de la Torre","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0575","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1532-5415.2007.01378.x","article-title":"Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease?","volume":"55","author":"Dede","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0580","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0585","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1179\/016164103101202048","article-title":"Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease","volume":"25","author":"Miklossy","year":"2003","journal-title":"Neurol Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0590","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood\u2013brain barrier disorder in Alzheimer's disease","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0595","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.neurobiolaging.2007.04.015","article-title":"Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus","volume":"29","author":"Zhang","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0600","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.lfs.2011.12.022","article-title":"Hypercholesterolemia accelerates intraneuronal accumulation of A\u03b2 oligomers resulting in memory impairment in Alzheimer's disease model mice","volume":"91","author":"Umeda","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0605","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/bmj.315.7115.1045","article-title":"Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype","volume":"315","author":"Kuusisto","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0610","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0615","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/archneur.62.10.noc50112","article-title":"Hyperinsulinemia provokes synchronous increases in central inflammation and amyloid in normal adults","volume":"62","author":"Fishel","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0620","first-page":"2","article-title":"Neuropsychological, neurophysiological and laboratory markers of direct brain injury in type 2 diabetes mellitus","volume":"3","author":"Hamed","year":"2012","journal-title":"J Neurol Neurosci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0625","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","article-title":"Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity","volume":"20","author":"Kruman","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0630","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1528-1157.2003.31702.x","article-title":"Neuronal cell death in hippocampus induced by homocysteic acid in immature rats","volume":"44","author":"Langmeier","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0635","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000319647.15752.7b","article-title":"Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study","volume":"71","author":"Cramer","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0640","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.mcn.2010.08.001","article-title":"Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits","volume":"45","author":"Ullrich","year":"2010","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0725","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.22062","article-title":"Visceral fat is associated with lower brain volume in healthy middle-aged adults","volume":"68","author":"Debette","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0645","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1042\/BST0331029","article-title":"Leptin: a potential cognitive enhancer?","volume":"33","author":"Harvey","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0650","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jcem.86.8.7763","article-title":"Insulin resistance as a predictor of age-related diseases","volume":"86","author":"Facchini","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0655","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.neuron.2008.04.014","article-title":"Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo","volume":"58","author":"Chiu","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0660","first-page":"3","article-title":"Cognitive function in patients with type 2 diabetes mellitus: relationship to stress hormone (cortisol)","volume":"4","author":"Hamed","year":"2013","journal-title":"J Neurol Neurosci"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0665","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/15672050113109990009","article-title":"Alzheimer disease and diabetes mellitus: do they have anything in common?","volume":"10","author":"Adeghate","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0670","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jalz.2013.08.279","article-title":"Time course of brain volume changes in the preclinical phase of Alzheimer's disease","volume":"10","author":"Bernard","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0675","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/S1355617703930013","article-title":"Extratemporal quantitative MR volumetrics and neuropsychological status in temporal lobe epilepsy","volume":"9","author":"Hermann","year":"2003","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0680","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1212\/01.WNL.0000058764.34968.C2","article-title":"MRI volumetry of the thalamus in temporal, extratemporal, and idiopathic generalized epilepsy","volume":"60","author":"Natsume","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0685","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2005.47604.x","article-title":"Seizure-associated abnormalities in epilepsy: evidence from MR imaging","volume":"46","author":"Briellmann","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0690","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/nan.12003","article-title":"The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease","volume":"39","author":"K\u00f6vari","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0695","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eplepsyres.2007.01.003","article-title":"Corpora amylacea in mesial temporal lobe epilepsy: clinico-pathological correlations","volume":"74","author":"Radhakrishnan","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0700","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/oby.2003.78","article-title":"Predictors of weight loss in adults with topiramate-treated epilepsy","volume":"11","author":"Ben-Menachem","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0705","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.yebeh.2011.11.024","article-title":"Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients","volume":"23","author":"Kim","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0710","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1532-5415.2008.02124.x","article-title":"New-onset epilepsy risk factors in older veterans","volume":"57","author":"Pugh","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0715","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1212\/WNL.0b013e3181f96253","article-title":"Statin use and risk of epilepsy: a nested case\u2013control study","volume":"75","author":"Etminan","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.003_bb0720","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/STROKEAHA.113.001886","article-title":"Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis","volume":"44","author":"Hankey","year":"2013","journal-title":"Stroke"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501400256X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501400256X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T18:10:12Z","timestamp":1717265412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501400256X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":143,"alternative-id":["S152550501400256X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.07.003","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atherosclerosis in epilepsy: Its causes and implications","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}